Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?

Laura Evangelista, PierFranco Conte, Cristina Ghiotto et al.|European Journal of Nuclear Medicine and Molecular Imaging|2015

Cited by 17